Back To: Home : Featured Technology : Reagents/Proteins

CLICK HERE FOR WHAT'S NEW IN:
 

Questcor Pharmaceuticals acquires BioVectra
February 2013
SHARING OPTIONS:

ANAHEIM, Calif.Questcor Pharmaceuticals Inc. has signed a definitive agreement to acquire all issued and outstanding shares of BioVectra Inc., for an upfront payment of nearly $50 million.   
 
Located in Prince Edward Island, Canada, BioVectra is a longtime partner to many top pharmas, supplying contract manufacturing services manufacturing active pharmaceutical ingredients (APIs), chemical intermediates and bioprocessing reagents. The company's capabilities include synthetic organic chemistry, natural extraction of bioactive compounds from plant and animal-based biomass sources, PEGylation and conjugation chemistry and fermentation of a variety of molecule types. BioVectra 's facilities have been approved by United States and Canadian regulatory authorities to produce and supply intermediates, APIs and drug substances.  
 
BioVectra has been Questcor's manufacturing partner for the API in Questcor's H.P. Acthar Gel (repository corticotropin injection) for nearly a decade.  
 
The acquisition will enable Questcor to further secure the manufacturing process trade secrets surrounding Acthar. BioVectra will continue to operate independently in Prince Edward Island under its existing management team, and Questcor intends to support the continued growth of BioVectra's business.
 
BioVectra's facilities are staffed by approximately 180 employees including chemists, engineers and technicians. BioVectra had sales of approximately $28 million in its last fiscal year ended Aug. 31, 2012, a 15-percent increase over its prior fiscal year.  
 
"We are excited to join efforts with BioVectra as we look to diversify our revenue," said Don M. Bailey, president and CEO of Questcor. "This action puts us in a better position to meet the continuing growth in demand for Acthar, brings to our company a broader depth of technical and scientific expertise, and provides us with a platform for potential international expansion."

Back


PAGE UTILITIES


CONTACT US
DDNEWS
478 Bay Street, Suite A213
Midland, Ontario, Canada L4R 1K9
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.